$PETS
PETMED EXPRESS INC

2023 Q2 Form 10-K Financial Statement

#000104013023000033 Filed on May 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2023
Revenue $78.24M $62.41M $256.9M
YoY Change 11.48% -5.45% -6.06%
Cost Of Revenue $55.72M $45.03M $185.8M
YoY Change 10.89% -3.39% -4.86%
Gross Profit $22.53M $17.38M $71.01M
YoY Change 12.95% -10.39% -9.05%
Gross Profit Margin 28.79% 27.85% 27.65%
Selling, General & Admin $22.98M $23.50M $68.90M
YoY Change 46.34% 101.66% 38.83%
% of Gross Profit 102.0% 135.2% 97.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.678M $994.0K $3.546M
YoY Change 122.84% 44.69% 29.51%
% of Gross Profit 7.45% 5.72% 4.99%
Operating Expenses $24.65M $24.49M $72.44M
YoY Change 49.85% 98.49% 38.34%
Operating Profit -$2.128M -$7.112M -$1.430M
YoY Change -160.97% -200.78% -105.56%
Interest Expense $620.0K $857.0K $2.070M
YoY Change 429.91% 831.52% 517.91%
% of Operating Profit
Other Income/Expense, Net $506.0K $226.0K $3.014M
YoY Change 60.63% -20.7% 121.45%
Pretax Income -$1.002M -$6.029M $1.584M
YoY Change -126.33% -181.1% -94.15%
Income Tax -$115.0K -$927.0K $1.351M
% Of Pretax Income 85.29%
Net Earnings -$887.0K -$5.102M $233.0K
YoY Change -131.96% -184.11% -98.9%
Net Earnings / Revenue -1.13% -8.18% 0.09%
Basic Earnings Per Share -$0.04 $0.01
Diluted Earnings Per Share -$0.04 -$0.25 $0.01
COMMON SHARES
Basic Shares Outstanding 21.17M shares 21.08M shares 20.28M shares
Diluted Shares Outstanding 20.33M shares 20.34M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.53M $104.1M $104.1M
YoY Change -41.63% -6.3% -6.3%
Cash & Equivalents $61.53M $104.1M $104.1M
Short-Term Investments
Other Short-Term Assets $10.08M $6.602M $6.602M
YoY Change 128.27% 19.02% 19.02%
Inventory $32.32M $19.02M $19.02M
Prepaid Expenses
Receivables $1.894M $1.740M $1.740M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $105.8M $131.5M $131.5M
YoY Change -21.13% -12.94% -12.94%
LONG-TERM ASSETS
Property, Plant & Equipment $29.23M $26.18M $26.18M
YoY Change 18.38% 7.01% 7.01%
Goodwill $20.74M $0.00
YoY Change
Intangibles $12.67M $5.860M
YoY Change 1373.37% 581.4%
Long-Term Investments $5.000M
YoY Change
Other Assets $7.270M $628.0K $628.0K
YoY Change 45.4%
Total Long-Term Assets $74.91M $32.67M $32.67M
YoY Change 145.17% 28.99% 28.99%
TOTAL ASSETS
Total Short-Term Assets $105.8M $131.5M $131.5M
Total Long-Term Assets $74.91M $32.67M $32.67M
Total Assets $180.7M $164.1M $164.1M
YoY Change 9.71% -6.92% -6.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.04M $25.21M $25.21M
YoY Change 135.08% -8.33% -8.33%
Accrued Expenses $14.04M $11.29M $10.03M
YoY Change 132.94% 98.16% 95.12%
Deferred Revenue $3.200M $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $57.32M $36.50M $36.50M
YoY Change 139.87% 9.94% 9.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.093M $3.825M $3.825M
YoY Change
Total Long-Term Liabilities $5.093M $3.825M $3.825M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $57.32M $36.50M $36.50M
Total Long-Term Liabilities $5.093M $3.825M $3.825M
Total Liabilities $62.42M $40.32M $40.32M
YoY Change 154.35% 18.13% 18.13%
SHAREHOLDERS EQUITY
Retained Earnings $98.26M $105.5M
YoY Change -22.62% -19.16%
Common Stock $21.00K $21.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $118.3M $123.8M $123.8M
YoY Change
Total Liabilities & Shareholders Equity $180.7M $164.1M $164.1M
YoY Change 9.71% -6.92% -6.92%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$887.0K -$5.102M $233.0K
YoY Change -131.96% -184.11% -98.9%
Depreciation, Depletion And Amortization $1.678M $994.0K $3.546M
YoY Change 122.84% 44.69% 29.51%
Cash From Operating Activities $562.0K $9.724M $27.80M
YoY Change -91.19% 11.55% 50.3%
INVESTING ACTIVITIES
Capital Expenditures $1.153M $1.931M $5.260M
YoY Change 17.41% -497.33% 200.23%
Acquisitions $35.86M $0.00
YoY Change
Other Investing Activities -$35.86M $0.00 -$5.000M
YoY Change 617.18%
Cash From Investing Activities -$37.01M -$1.931M -$10.26M
YoY Change 518.72% 297.33% 485.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.102M -6.135M -$24.54M
YoY Change 0.63% 1.2% 0.63%
NET CHANGE
Cash From Operating Activities 562.0K 9.724M $27.80M
Cash From Investing Activities -37.01M -1.931M -$10.26M
Cash From Financing Activities -6.102M -6.135M -$24.54M
Net Change In Cash -42.55M 1.658M -$6.994M
YoY Change 651.01% -23.56% -8.43%
FREE CASH FLOW
Cash From Operating Activities $562.0K $9.724M $27.80M
Capital Expenditures $1.153M $1.931M $5.260M
Free Cash Flow -$591.0K $7.793M $22.54M
YoY Change -110.95% -15.32% 34.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001040130
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-28827
CY2023 dei Entity Registrant Name
EntityRegistrantName
PETMED EXPRESS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0680967
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
420 South Congress Avenue
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Delray Beach
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33445
CY2023 dei City Area Code
CityAreaCode
561
CY2023 dei Local Phone Number
LocalPhoneNumber
526-4444
CY2023 dei Security12b Title
Security12bTitle
Common Stock, PETS $.001 Par value per share
CY2023 dei Trading Symbol
TradingSymbol
PETS
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
396400000 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21170977 shares
CY2023 dei Auditor Firm
AuditorFirmId
49
CY2023 dei Auditor Name
AuditorName
RSM US LLP
CY2023 dei Auditor Location
AuditorLocation
Fort Lauderdale, Florida
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104086000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111080000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1740000 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1913000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19023000 usd
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
32455000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4719000 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4866000 usd
CY2023Q1 us-gaap Prepaid Taxes
PrepaidTaxes
1883000 usd
CY2022Q1 us-gaap Prepaid Taxes
PrepaidTaxes
681000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
131451000 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
150995000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26178000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24464000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5860000 usd
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
628000 usd
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
32666000 usd
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
25324000 usd
CY2023Q1 us-gaap Assets
Assets
164117000 usd
CY2022Q1 us-gaap Assets
Assets
176319000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
25208000 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
27500000 usd
CY2023Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
11289000 usd
CY2022Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5697000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
36497000 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
33197000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
936000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3825000 usd
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q1 us-gaap Liabilities
Liabilities
40322000 usd
CY2022Q1 us-gaap Liabilities
Liabilities
34133000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000 shares
CY2022Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2023Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000 usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000 usd
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21084000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21084000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20979000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20979000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
21000 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
21000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18277000 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11660000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
105488000 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
130496000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
123795000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
142186000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
164117000 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176319000 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
256858000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
273417000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
309215000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
185844000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
195341000 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
219267000 usd
CY2023 us-gaap Gross Profit
GrossProfit
71014000 usd
CY2022 us-gaap Gross Profit
GrossProfit
78076000 usd
CY2021 us-gaap Gross Profit
GrossProfit
89948000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49474000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30829000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28293000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
19424000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
18799000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
21641000 usd
CY2023 us-gaap Depreciation
Depreciation
3546000 usd
CY2022 us-gaap Depreciation
Depreciation
2738000 usd
CY2021 us-gaap Depreciation
Depreciation
2427000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
72444000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
52366000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
52361000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1430000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
25710000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
37587000 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
2070000 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
335000 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
314000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
944000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1026000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1315000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3014000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1361000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1629000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1584000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27071000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39216000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1351000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5971000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8613000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
233000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
21100000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
30603000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20275000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20176000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20060000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20339000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20358000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20119000 shares
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.20
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.20
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.12
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
130010000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3307000 usd
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
22639000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
30603000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
141281000 usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4549000 usd
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
24745000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
21100000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
142186000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6617000 usd
CY2023 us-gaap Dividends Common Stock
DividendsCommonStock
25241000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
233000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
123795000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
233000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
21100000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
30603000 usd
CY2023 us-gaap Depreciation
Depreciation
3546000 usd
CY2022 us-gaap Depreciation
Depreciation
2738000 usd
CY2021 us-gaap Depreciation
Depreciation
2427000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6617000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4549000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3307000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1564000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-345000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
311000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
214000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
165000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
130000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
41000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-509000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1126000 usd
CY2023 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-13432000 usd
CY2022 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-1965000 usd
CY2021 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
16536000 usd
CY2023 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
1202000 usd
CY2022 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-278000 usd
CY2021 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
959000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-147000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
363000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
974000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2292000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12048000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19890000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
8713000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-50000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1221000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-471000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27803000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18498000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40075000 usd
CY2023 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
5000000 usd
CY2022 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
0 usd
CY2021 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
0 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5260000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1752000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2432000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10260000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1752000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2432000 usd
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24537000 usd
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24384000 usd
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22687000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24537000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24384000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22687000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6994000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7638000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14956000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
111080000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
118718000 usd
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103762000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
104086000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
111080000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
118718000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4312000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6085000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10018000 usd
CY2023 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1262000 usd
CY2022 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
558000 usd
CY2021 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
198000 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
256858000 usd
CY2023 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
273417000 usd
CY2022 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2023 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-16559000 usd
CY2023 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.061
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
256858000 usd
CY2023 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
273417000 usd
CY2022 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2023 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-16559000 usd
CY2023 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.061
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
273417000 usd
CY2022 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
309215000 usd
CY2021 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2022 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-35798000 usd
CY2022 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.116
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
273417000 usd
CY2022 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
309215000 usd
CY2021 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2022 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-35798000 usd
CY2022 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.116
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26178000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
48000 usd
CY2022Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
81000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Concentrations</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. We have multiple suppliers for each of our product lines to obtain the lowest cost. There were six suppliers from which we purchased approximately 69% and 77% of all products in fiscal 2023 and 2022, respectively.</span></div>
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
41409000 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36149000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15231000 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11685000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24464000 usd
CY2023Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
5098000 usd
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1106000 usd
CY2023Q1 pets Accrued Credit Card Fees Current
AccruedCreditCardFeesCurrent
401000 usd
CY2022Q1 pets Accrued Credit Card Fees Current
AccruedCreditCardFeesCurrent
428000 usd
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1564000 usd
CY2022Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1134000 usd
CY2023Q1 pets Accrued Merchandise Credits And Rewards Current
AccruedMerchandiseCreditsAndRewardsCurrent
1660000 usd
CY2022Q1 pets Accrued Merchandise Credits And Rewards Current
AccruedMerchandiseCreditsAndRewardsCurrent
1623000 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
559000 usd
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
459000 usd
CY2023Q1 pets Accrued Sales Returns And Allowances Current
AccruedSalesReturnsAndAllowancesCurrent
221000 usd
CY2022Q1 pets Accrued Sales Returns And Allowances Current
AccruedSalesReturnsAndAllowancesCurrent
190000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
1262000 usd
CY2022Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
558000 usd
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
118000 usd
CY2022Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
111000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
406000 usd
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
88000 usd
CY2023Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
11289000 usd
CY2022Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5697000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1529000 usd
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
364000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1605000 usd
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
662000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
21000 usd
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
27000 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3155000 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1053000 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2527000 usd
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1989000 usd
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
628000 usd
CY2022Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
936000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1831000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5801000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7446000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1084000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
515000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
856000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2915000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6316000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8302000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-982000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-317000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
279000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-582000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-28000 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
32000 usd
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1564000 usd
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-345000 usd
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
311000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1351000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5971000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8613000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
333000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5685000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
8235000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
275000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
379000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
708000 usd
CY2023 pets Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
396000 usd
CY2022 pets Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
59000 usd
CY2021 pets Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
198000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
208000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
33000 usd
CY1998Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-135000 usd
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
139000 usd
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-185000 usd
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-393000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1351000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5971000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8613000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
208000 usd
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
382000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
33000 usd
CY2022 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-29000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-135000 usd
CY2021 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-194000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.174
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.014
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.018
CY2023 pets Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.250
CY2022 pets Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.002
CY2021 pets Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.005
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.131
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.088
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.006
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.010
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.853
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.221
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.220
CY1998Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
250000 shares
CY1998Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY1998Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
112000 usd
CY1998Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
4.05 shares
CY1998Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4.00
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
110000000 usd
CY2023 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2022 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28700000 usd
CY2022Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.30
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
6297000 usd
CY2022Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.30
CY2022Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
6323000 usd
CY2022Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.30
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
6323000 usd
CY2023Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.30
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111100000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
6325000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6600000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4500000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3300000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
771000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
127000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
118000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
27000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
753000 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104100000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
233000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
21100000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
30603000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20275000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20176000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20060000 shares
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
54000 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
172000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
49000 shares
CY2023 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000 shares
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20339000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20358000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20119000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
745854 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
220727 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20952 shares
CY2023 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
7800000 usd
CY2021Q4 pets Lump Sum Severance Payments
LumpSumSeverancePayments
325000 usd
CY2023 us-gaap Deferred Compensation Arrangement With Individual Requisite Service Period1
DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
P1Y
CY2023 pets Defined Contribution Plan With Individual Age
DefinedContributionPlanWithIndividualAge
P21Y
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2023 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
289000 usd
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
238000 usd
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
245000 usd

Files In Submission

Name View Source Status
0001040130-23-000033-index-headers.html Edgar Link pending
0001040130-23-000033-index.html Edgar Link pending
0001040130-23-000033.txt Edgar Link pending
0001040130-23-000033-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pets-20230331.htm Edgar Link pending
pets-20230331.xsd Edgar Link pending
pets-20230331xexx1071.htm Edgar Link pending
pets-20230331xexx211.htm Edgar Link pending
pets-20230331xexx231.htm Edgar Link pending
pets-20230331xexx311.htm Edgar Link pending
pets-20230331xexx312.htm Edgar Link pending
pets-20230331xexx321.htm Edgar Link pending
pets-20230331xexx42.htm Edgar Link pending
pets-20230331_g1.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pets-20230331_def.xml Edgar Link unprocessable
pets-20230331_lab.xml Edgar Link unprocessable
pets-20230331_cal.xml Edgar Link unprocessable
pets-20230331_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pets-20230331_pre.xml Edgar Link unprocessable